Table 1.
Demographic and Clinical Information of Participants
ID | Age, y | Sex | Marital status | Diagnosis | Time since diagnosis, mo | Treatment | Medicationsb | PSQI SD group | Caregiver ID | Age, y | Sex | Employment | Duration of care, mo | PSQI SD group |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pt 1 | 66 | M | Married | PBT (Grade IV) | 2 | Anti-emetic, anti-convulsant | PS | Cr 1 | 63 | F | Retired | 3 | PS | |
Pt 2 | 59 | M | Single | MBT | 11 | Anti-convulsant | PS | Cr 2 | 79 | F | Retired | 12 | GS | |
Pt 3 | 47 | M | Married | PBT (Grade IV) | 4 | Chemotherapya | Anti-emetic | PS | Cr 3 | 45 | F | Leave of absence | 4 | GS |
Pt 4 | 55 | M | Married | PBT (Grade II) | 240 | Anti-convulsant | PS | Cr 4 | 51 | F | Leave of absence | 9 | PS | |
Pt 5 | 62 | F | Married | PBT (Grade IV) | 7 | Chemotherapy | Anti-convulsant | PS | Cr 5 | 64 | M | Part-time/casual | 12 | PS |
Pt 6 | 36 | F | Married | PBT (Grade III) | 28 | Chemotherapy | Anti-convulsant | GS | Cr 6 | 35 | M | Full-time | 29 | GS |
Pt 7 | 24 | M | Single | PBT (Grade IV) | 41 | Chemotherapy | PS | |||||||
Pt 8 | 61 | F | Married | MBT | 25 | Chemotherapy (Olaparib) | PS | Cr 8 | 66 | M | Retired | 40 | PS | |
Pt 9 | 53 | M | Married | MBT | 2 | Corticosteroids anti-convulsant anti-emetic | PS | |||||||
Pt 10 | 55 | M | Married | PBT (Grade II) | 71 | Anti-convulsant | GS | Cr 10 | 52 | F | Full-time | 72 | PS | |
Pt 11 | 55 | M | Married | Primary CNS Lymphoma | 9 | Whole-brain radiation, R-MVBP (chemo) | Opioid dependence, anti-convulsant corticosteroid, anti-emetic | PS | ||||||
Pt 12 | 44 | M | Married | PBT (Grade II) | 36 | GS | ||||||||
Pt 13 | 34 | F | Married | PBT (Grade IV) | 17 | Chemotherapy | Anti-emetic | PS | ||||||
Pt 14 | 30 | F | Single | PBT (Grade IV) | 5 | Chemotherapy | GS | |||||||
Pt 15 | 56 | F | Married | PBT (Grade III) | 9 | Chemotherapy | Anti-convulsant | GS | ||||||
Pt 16 | 61 | M | Married | PBT (Grade III) | 384 | GS | Cr 16 | 59 | F | Part-time/casual | 14 | PS | ||
Pt 17 | 50 | F | Married | PBT (Grade II) | 86 | Chemotherapy | PS | Cr 17 | 57 | M | Retired | 72 | PS | |
Pt 18 | 74 | M | Married | PBT (Grade III) | 12 | Chemotherapy | Anti-convulsant | GS | Cr 18 | 69 | F | Retired | 12 | GS |
Pt 19 | 43 | F | Married | PBT (Grade III) | 36 | PS | ||||||||
Pt 20 | 71 | M | Married | PBT (Grade III) | 36 | Chemotherapy | PS | Cr 20 | 71 | F | Retired | 36 | PS | |
Pt 21 | 53 | F | Married | PBT (Grade IV) | 11 | Chemotherapy | Anti-convulsant, anti-depressant, anti-emetic | PS | Cr 21 | 54 | M | Full-time | 10 | PS |
Pt 22 | 70 | M | Married | PBT (Grade IV) | 41 | Chemotherapy (Lomustine) | Corticosteroids, sedative (melatonin) | PS | Cr 22 | 58 | F | Retired | 42 | PS |
Pt 23 | 46 | M | Married | PBT (Grade III) | 93 | Chemotherapy | Anti-convulsant corticosteroids | GS | ||||||
Pt 24 | 61 | F | Married | PBT (Grade IV) | 7 | Chemotherapy | PS |
aChemotherapy agent was Temozolomide, unless specified otherwise.
bMedications that can potentially alter sleep are listed.
Note. Treatment and medications were current at the time of interview.
Abbreviations: Pt, patient; Cr, caregiver; M, male; F, female; PBT, primary brain tumor; MBT, metastatic brain tumor; PSQI, Pittsburgh Sleep Quality Index; SD, sleep disturbance; PS, poor sleeper (PSQI > 5); GS, good sleeper (PSQI ≤ 5).